First Wave
United States · Founded 2014
- Headquarters
- Florida
- Founded
- 2014
- Business Model
- B2B
- Website
- firstwavebio.com
About
First Wave BioPharma, Inc. (Nasdaq: FWBI) is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases. The company's pipeline includes adrulipase, a Phase II-stage treatment, along with additional unlicensed GI-focused assets. In 2024, First Wave BioPharma completed a business combination with ImmunogenX, adding Phase 3-ready latiglutenase (for celiac disease) to its late-stage GI-focused clinical pipeline. The combined company is focused on advancing multiple non-systemic GI therapeutics addressing significant unmet medical needs.
Summary
First Wave is a Biotech company based in United States, founded in 2014.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company